Tumor necrosis factor (TNF) plays important roles in host resistance to cancer and infections, but this cytokine also acts as a key mediator of pathologies in autoimmunity, septic shock and cachexia. The long-term goal of our studies is to explain the molecular mechanisms whereby TNF produces its important biological actions. Elucidation of intracellular signaling pathways is essential for understanding how TNF and other related cytokines produce the multitude of their actions as well as for the design of methods that would inhibit their undesirable effects in the intact organism. In this application we propose to determine the roles played by members of the large family of mitogen activated protein (MAP) kinases in TNF actions. The hypothesis to be examined is that the ERK, JNK/SAPK and p38 MAP kinases are important mediators of TNF actions and that each of these MAP kinase subfamilies plays specific roles in the different cellular functions activated by TNF. The first specific aim is to determine the roles of the major MAP kinase subfamilies in the activation of gene expression by TNF. Toward this end we shall analyze the involvement of MAP kinases in the TNF-induced activation of the IL-6 and IL-8 genes in which the roles of specific transcription factors (especially NF-kappaB and NF-IL6) have been extensively documented. We shall also determine the roles of MAP kinases on the activation of genes responsive to the AP-1 and IRF-1 transcription factors. The second specific aim is to determine the mechanism whereby the p38 kinase mediates inhibition of TNF-induced NF-kappaB activation. We shall determine whether p38 activation alone is sufficient to inhibit TNF- induced I-kappaBalpha phosphorylation and degradation, and which of the intracellular signaling proteins known to mediate NF-kappaB activation by the p55 TNF receptor is the target of the inhibitory action mediated by p38. These studies will help to understand signaling pathways activated by TNF and will contribute to the design of methods for the inhibition of undesirable side effects of TNF in pathological conditions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA075071-03
Application #
6150308
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Spalholz, Barbara A
Project Start
1998-04-15
Project End
2003-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
3
Fiscal Year
2000
Total Cost
$336,115
Indirect Cost
Name
New York University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Wisniewski, Hans-Georg; Vilcek, Jan (2004) Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev 15:129-46
Szatmary, Zoltan; Garabedian, Michael J; Vilcek, Jan (2004) Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem 279:43708-15
Ahn, J H; Park, S M; Cho, H S et al. (2001) Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J Biol Chem 276:47100-6
Dias, A A; Goodman, A R; Dos Santos, J L et al. (2001) TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol 69:928-36
Alpert, D; Vilcek, J (2000) Inhibition of IkappaB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells. J Biol Chem 275:10925-9
Goodman, A R; Levy, D E; Reis, L F et al. (2000) Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. J Leukoc Biol 67:387-95
Mindrescu, C; Thorbecke, G J; Klein, M J et al. (2000) Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein. Arthritis Rheum 43:2668-77
Poppers, D M; Schwenger, P; Vilcek, J (2000) Persistent tumor necrosis factor signaling in normal human fibroblasts prevents the complete resynthesis of I kappa B-alpha. J Biol Chem 275:29587-93
Alpert, D; Schwenger, P; Han, J et al. (1999) Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation. J Biol Chem 274:22176-83
Gerecitano, J; Perle, M A; Vilcek, J (1999) Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines. J Interferon Cytokine Res 19:393-405

Showing the most recent 10 out of 11 publications